Correction: Disruption of FGF5 in Cashmere Goats Using CRISPR/Cas9 Results in More Secondary Hair Follicles and Longer Fibers.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. CRISPR-Cas9 in the Tailoring of Genetically Engineered Animals.Current issues in molecular biology · 2025
   Review
2. FGF5 Regulates Schwann Cell Migration and Adhesion.Frontiers in cellular neuroscience · 2020
   Article
3. Analyses of histological and transcriptome differences in the skin of short-hair and long-hair rabbits.BMC genomics · 2019
   Article
4. Principles of gene editing techniques and applications in animal husbandry.3 Biotech · 2019
   Review

Corrections and comments

• Erratum for
  Disruption of FGF5 in Cashmere Goats Using CRISPR/Cas9 Results in More Secondary Hair Follicles and Longer Fibers.2016

Authors and funding

16 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract